World's Best Scientists 2026 revealed!
Anthony L. Zietman

Anthony L. Zietman

D-Index & Metrics

Medicine

D-Index
91
Citations
33545
World Ranking
11679
National Ranking
5986

Overview

Anthony L. Zietman is affiliated with Harvard University in the United States and has a significant body of research in the field of medicine, focusing primarily on oncology and urology. Their work spans several subfields including pulmonary and respiratory medicine, surgery, radiology, nuclear medicine and imaging, radiation, and oncology.

The scientist's main research topics cover a range of areas in cancer diagnosis, treatment, and radiotherapy. These include prostate cancer diagnosis and treatment, prostate cancer treatment and research, bladder and urothelial cancer treatments, advanced radiotherapy techniques, urinary and genital oncology studies, advances in oncology and radiotherapy, and cancer immunotherapy and biomarkers.

They have published extensively with frequent appearances in the following venues:

  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • The Journal of Urology
  • British Journal of Urology
  • The Lancet Oncology

Frequent collaborators include:

  • Jason A. Efstathiou (27 publications)
  • Sophia C. Kamran (20 publications)
  • William U. Shipley (17 publications)
  • David T. Miyamoto (15 publications)
  • Douglas M. Dahl (12 publications)

Significant recent papers authored or co-authored by Anthony L. Zietman include:

  • "Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I," 2020, The Journal of Urology
  • "Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis," 2023, The Lancet Oncology
  • "Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II," 2020, The Journal of Urology
  • "Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer," 2020, JAMA Oncology
  • "Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality," 2024, JAMA

The diversity of publication venues and the volume of research underscore their focus on clinical and research advances related to radiation and cancer treatment, with particular expertise in prostate and bladder cancers. This reflects interdisciplinary efforts combining oncology, radiology, surgery, and immunotherapy to advance therapeutic strategies and patient outcomes.

Best Publications

  • Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate : A randomized controlled trial

    Anthony L. Zietman;Michelle L. DeSilvio;Jerry D. Slater;Carl J. Rossi

  • Early detection of prostate cancer: AUA Guideline

    H. Ballentine Carter;Peter C. Albertsen;Michael J. Barry;Ruth Etzioni

  • Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09

    Anthony L. Zietman;Kyounghwa Bae;Jerry D. Slater;William U. Shipley

  • Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

    Sam S. Chang;Bernard H. Bochner;Roger Chou;Robert Dreicer

  • Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.

    Matthew R. Smith;Francis J. McGovern;Anthony L. Zietman;Mary Anne Fallon

  • Changes in body composition during androgen deprivation therapy for prostate cancer.

    Matthew R. Smith;Joel S. Finkelstein;Francis J. McGovern;Anthony L. Zietman

  • Prostate Specific Antigen Best Practice Statement: 2009 Update

    Kirsten L. Greene;Peter C. Albertsen;Richard J. Babaian;H. Ballentine Carter

  • Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

    William U. Shipley;Wendy Seiferheld;Himanshu R. Lukka;Pierre P. Major

  • Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.

    Peter Grimm;Ignace Billiet;David Bostwick;Adam P Dicker

  • Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

    William U. Shipley;Lynn J. Verhey;John E. Munzenrider;Herman D. Suit

  • Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.

    Michael J. Zelefsky;Deborah A. Kuban;Larry B. Levy;Louis Potters

  • Pelvic normal tissue contouring guidelines for radiation therapy: A radiation therapy oncology group consensus panel atlas

    H. Joseph Barthold;Elizabeth O'Meara;Walter R. Bosch

  • Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

    William U. Shipley;Howard D. Thames;Howard M. Sandler;Gerald E. Hanks

  • Outcomes of localized prostate cancer following conservative management.

    Grace L. Lu-Yao;Peter C. Albertsen;Dirk F. Moore;Weichung Shih

  • American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy

    Brian J. Davis;Eric M. Horwitz;W. Robert Lee;Juanita M. Crook

  • Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.

    Floyd J. Fowler;Mary McNaughton Collins;Peter C. Albertsen;Anthony Zietman

  • Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience

    Jason A. Efstathiou;Daphna Y. Spiegel;William U. Shipley;Niall M. Heney

  • Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233

    Raymond H. Mak;Daniel Hunt;William U. Shipley;Jason A. Efstathiou

  • Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer

    W.U Shipley;D.S Kaufman;E Zehr;N.M Heney

  • Development of RTOG Consensus Guidelines for the Definition of the Clinical Target Volume for Postoperative Conformal Radiation Therapy for Prostate Cancer

    Jeff M. Michalski;Colleen Lawton;Issam El Naqa;Mark Ritter

Frequent Co-Authors

William U. Shipley
William U. Shipley Harvard University
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
Deborah A. Kuban
Deborah A. Kuban The University of Texas MD Anderson Cancer Center
Jeff M. Michalski
Jeff M. Michalski Washington University in St. Louis
Michael J. Zelefsky
Michael J. Zelefsky Memorial Sloan Kettering Cancer Center
Howard D. Thames
Howard D. Thames The University of Texas MD Anderson Cancer Center
Patrick A. Kupelian
Patrick A. Kupelian University of California, Los Angeles
Eric M. Horwitz
Eric M. Horwitz Fox Chase Cancer Center
Alvaro Martinez
Alvaro Martinez Beaumont Health
Paul L. Nguyen
Paul L. Nguyen Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA opens doors to many related online degree options, each offering distinct pathways in healthcare. If you’re interested in leadership roles, consider the cheapest online healthcare administration degree to combine medical knowledge with management skills.

For those seeking advanced expertise, there are affordable mha online programs and even the cheapest dnp options. These programs help students move into senior roles, such as executive positions or advanced clinical practice, at a lower cost than traditional on-campus options.

Pharmacists are also crucial to healthcare teams. If pharmacy piques your interest, look into online pharmacy programs to pursue this rewarding profession with more flexibility.

By researching affordable online degrees, you can chart a healthcare career path that fits both your professional aspirations and your budget.

Best Scientists Citing Anthony L. Zietman

Trending Scientists

Recently Published Articles